Youquhui (02177) reaches strategic cooperation with Pobao to jointly create a new blueprint for the precise probiotic market.
Yooquoo (02177) and PrecisionBiotics, a high-end original probiotics brand under the Nuohexin Group, held a grand strategic cooperation signing ceremony in Guangzhou.
On May 22nd, Youquhui (02177) and the high-end probiotic brand PrecisionBiotics under the umbrella of Novozymes held a grand strategic cooperation signing ceremony in Guangzhou. Mr. Cheng Xian, the head of Novozymes Consumer Health Asia Pacific, and Mr. Wang Yibing, the head of Youquhuis Health Food Business Department, attended the ceremony. This cooperation will fully integrate Youquhui's professional strengths in brand operation with PrecisionBiotics' deep technical expertise in precise and effective probiotic research and development, jointly exploring the Chinese health e-commerce market to bring more scientifically effective probiotic products to consumers.
PrecisionBiotics originated from the laboratory of University College Cork in Ireland and has been researching human microbiota for 25 years. With its research team's strong professional background in microbiology, it has gained high recognition in strain identification, gene expression analysis, and precise screening. The brand focuses on precise and effective probiotic solutions, with its probiotic products selected from natural strains found in the human gut to ensure safety and efficacy, effectively helping consumers with specific health issues faced in modern life. Its Alforex dual probiotic product, specifically tailored for Irritable Bowel Syndrome (IBS), combines scientifically validated strains Bifidobacterium longum 35624 and Bifidobacterium longum 1714 to work together. Research has shown that it can improve the intestinal environment and significantly alleviate symptoms such as abdominal pain, diarrhea, constipation, and bloating. Additionally, it has a positive effect on stress relief, sleep aid, and mood regulation.
In this strategic cooperation, both parties will engage in deep collaboration on multiple dimensions. Youquhui will leverage its rich experience in e-commerce platform operation, marketing promotion, and supply chain management to help PrecisionBiotics accurately reach Chinese consumers and enhance the brand's market share in China.
Related Articles

China Risun GP (01907) spent approximately 4.9571 million Hong Kong dollars to repurchase 1.998 million shares on May 23rd.

LHN (01730) sold its equity in the asset at 115 Geylang Road for 25.8 million Singapore dollars.

Guangzhou Automobile Group (02238) will distribute a final dividend of HK$0.02175 per share on July 2nd.
China Risun GP (01907) spent approximately 4.9571 million Hong Kong dollars to repurchase 1.998 million shares on May 23rd.

LHN (01730) sold its equity in the asset at 115 Geylang Road for 25.8 million Singapore dollars.

Guangzhou Automobile Group (02238) will distribute a final dividend of HK$0.02175 per share on July 2nd.

RECOMMEND

Xiaomi Unveils 3nm Chip and YU7 SUV at 15th Anniversary Event
23/05/2025

BYD Surpasses Tesla in European EV Sales for the First Time in April with 169% Surge; Tesla Sees 45% Q1 Decline, Musk Reaffirms CEO Role for Five More Years
23/05/2025

U.S. FTC Officially Withdraws Case Against Microsoft’s $69 Billion Acquisition of Activision Blizzard
23/05/2025